Greater Than 95% Purity Recombinant PK For Covid – 19 Nucleic Acid Detection

Description

Proteinase K was first discovered in the extract of Engyodontium album in 1974. It is a serine protease belonging to the S8 family of the serine protease S8 superfamily. Its molecular mass is about 29 kilodaltons. It can digest natural keratin, hence, named proteinase K. Proteinase K has a wide range of cleavage capabilities. Its main cleavage site is the carboxy-terminal peptide bond of aliphatic threonine and aromatic amino acids, which is one of the most widely used proteinase in lifa science.

Since 2020, the Covid-19 coronavirus epidemic has spread rapidly around the world, and the demand for nucleic acid detection of the Covid-19 has continued to increase. As one of the extraction reagents for Covid-19 nucleic acid, the demand of proteinase K in the market has also greatly increased. However, the productivity of many proteinase K manufacturers cannot meet the expanding market demand, which has led to the shortage Covid-19 nucleic acid testing reagents always.

Healthgen Biotech's recombinant proteinase K(rProK) is extracted from yeast, and its structure and biological function are consistent with those of natural proteinase K. Moreover, due to its world-leading protein purification platform (Oryz^HiPur), the purity of Healthgen Biotech 's proteinase K has reached greater than 95%, and its strong productivity enables the production level of proteinase K to reach 50kg/month. Correspondingly, the cost has also been greatly reduced, and the bulk and stable supply can fully meet the large demands of manufacturers and testing laboratories for Covid-19 nucleic acid testing reagents.

Detail:

Other Names: Recombinant ProK, rPK, Proteinase K, rProK, PK

Place of Origin: Wuhan, China (Mainland)

Brand Name: Oryzogen

Model Number: HYC032R03